Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 28, 2026

Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
10:10

Quantifying Cognitive Decrements Caused by Cranial Radiotherapy

Published on: October 18, 2011

Quantifying cognitive decrements caused by cranial radiotherapy.

Lori-Ann Christie1, Munjal M Acharya, Charles L Limoli

  • 1Department of Radiation Oncology, University of California Irvine, USA.

Journal of Visualized Experiments : Jove
|November 2, 2011
PubMed
Summary

Transplanted human neural stem cells (hNSCs) show promise in improving cognitive function in rats after cranial irradiation. This study demonstrates a potential new therapy for cancer survivors experiencing radiation-induced cognitive decline.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sustained AMPAR expression in CA3 neurons may mediate neuroprotection following FLASH-RT.

Cell reports·2026
Same author

Spatial Transcriptomics reveals a T cell-mediated microglial activation axis of neurodegeneration following immune checkpoint inhibition.

bioRxiv : the preprint server for biology·2026
Same author

Catalpol reverses doxorubicin-induced cognitive decline, neuroinflammation, and restores synaptic integrity.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Same author

Neuroprotection following FLASH-RT may be mediated by sustained glutamate receptor AMPAR activation in CA3 neurons.

bioRxiv : the preprint server for biology·2026
Same author

Cannabidiol alleviates chemotherapy-induced cognitive decline and neuropathology.

Cancer letters·2026
Same author

Human neural stem cell-derived extracellular vesicles improve cognitive function following glioma chemoradiation therapy.

Cancer letters·2026

Area of Science:

  • Neuroscience
  • Oncology
  • Regenerative Medicine

Background:

  • Cancer treatments like radiotherapy can cause significant cognitive impairment, especially in brain tumor patients.
  • Pediatric cancer survivors face long-term cognitive deficits, leading to socioeconomic burdens.
  • Current solutions for radiation-induced cognitive dysfunction are limited.

Purpose of the Study:

  • To investigate the efficacy of transplanted human neural stem cells (hNSCs) in mitigating cognitive decline following cranial irradiation.
  • To establish a preclinical model for evaluating interventions against radiation-induced cognitive sequelae.

Main Methods:

  • Athymic rats underwent stereotaxic cranial irradiation and subsequent transplantation of hNSCs.
  • Cognitive function was assessed using a battery of tests including novel place recognition, water maze, elevated plus maze, and fear conditioning.

More Related Videos

Stem Cell Transplantation Strategies for the Restoration of Cognitive Dysfunction Caused by Cranial Radiotherapy
11:24

Stem Cell Transplantation Strategies for the Restoration of Cognitive Dysfunction Caused by Cranial Radiotherapy

Published on: October 18, 2011

Related Experiment Videos

Last Updated: May 28, 2026

Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
10:10

Quantifying Cognitive Decrements Caused by Cranial Radiotherapy

Published on: October 18, 2011

Stem Cell Transplantation Strategies for the Restoration of Cognitive Dysfunction Caused by Cranial Radiotherapy
11:24

Stem Cell Transplantation Strategies for the Restoration of Cognitive Dysfunction Caused by Cranial Radiotherapy

Published on: October 18, 2011

  • Grafted cell survival and differentiation markers were evaluated at 1 and 4 months post-transplantation.
  • Main Results:

    • Irradiated rats engrafted with hNSCs demonstrated significant improvements in cognitive function compared to controls.
    • The study validated the use of specific cognitive tasks to quantify radiation-induced deficits.
    • hNSC transplantation was shown to be a viable strategy for ameliorating cognitive impairments.

    Conclusions:

    • Transplanted hNSCs offer a potential therapeutic strategy to restore cognitive function in cancer survivors treated with cranial radiotherapy.
    • This research provides a foundation for developing clinical applications to address cognitive dysfunction in cancer patients.
    • Further development of stem cell-based therapies could significantly improve the quality of life for cancer survivors.